Edaravone

Edaravone is a prescription intravenous solution used for medical treatment, available in strengths of 30 mg/100 mL (0.3 mg/mL) and 60 mg/100 mL (0.6 mg/mL). Manufactured by XGen Pharmaceuticals DJB, Inc., it is approved under ANDA217565 and marketed as a single-dose vial. This information was generated using AI and is provided for informational and research purposes only.